Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-06-02T14:28:41.833Z Has data issue: false hasContentIssue false

A Founder Mutation in French-Canadian Families with X-linked Hereditary Neuropathy

Published online by Cambridge University Press:  02 March 2017

Nicolas Dupré
Affiliation:
Laboratoire de Recherche en Génétique Humaine, CHU Laval, Canada
Louise Cossette
Affiliation:
Laboratoire de Recherche en Génétique Humaine, CHU Laval, Canada
Collette K. Hand
Affiliation:
Center for Research in Neuroscience, McGill University and the Institut de Recherche, Hôpital Général de Montréal, Montréal, Canada
Jean-Pierre Bouchard
Affiliation:
Département des Sciences Neurologiques, Hôpital Enfant-Jésus, QuébecCanada
Guy A Rouleau
Affiliation:
Center for Research in Neuroscience, McGill University and the Institut de Recherche, Hôpital Général de Montréal, Montréal, Canada
Jack Puymirat*
Affiliation:
Laboratoire de Recherche en Génétique Humaine, CHU Laval, Canada
*
Laboratoire de Recherche en Génétique Humaine, CHU Laval, 2705 Blvd Laurier, Ste-Foy, Québec, G1V4G2, Canada.
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

The aim of the present study was to identify the mutations in the connexin 32 gene in French-Canadian families with X-linked Charcot-Marie-Tooth disease (CMTX).

Methods:

Molecular analysis was performed by nonisotopic single strand conformation polymorphism (SSCP) analysis and sequencing. Clinical evaluation was carried out according to the scale defined by the European Hereditary Motor and Sensory Neuropathy Consortium.

Results:

In one family, the mutation Arg142Trp was located in the transmembrane domain III whereas, in four other families we identified a novel mutation (Ser26Trp) located in the transmembrane domain I of the connexin 32 gene. Haplotype analysis revealed that these four families are related and suggests a founder mutation. Sixteen patients from these four families were studied. As expected, all the affected males were more clinically affected than the females and all affected patients exhibited some electrophysiological characteristics of demyelination.

Conclusion:

Our study suggests that the Ser26Trp mutation may cause a primary demyelinating neuropathy that is not associated with a specific clinical phenotype. We also find evidence that the majority of kindreds share a common ancestor.

Résumé:

RÉSUMÉ:Introduction:

Le but de cette étude était d'identifier les mutations du gène de la connexine 32 chez des familles canadiennes-françaises atteintes de la maladie de Charcot-Marie-Tooth liée à l'X (CMTX).

Méthodes:

L'analyse moléculaire a été faite par polymorphisme de conformation d'ADN simple brin non isotopique et séquençage. L'évaluation clinique a été effectuée selon l'échelle définie par le Consortium HMSN Européen.

Résultats:

Dans une famille, la mutation Arg142Trp a été localisée dans le domaine transmembranaire III alors que chez quatre autres familles, nous avons identifié une nouvelle mutation (Ser26Trp) localisée dans le domaine transmembranaire I du gène Cx32. L'analyse des haplotypes a montré que ces quatre familles sont apparentées et suggère qu'il s'agit d'une mutation fondatrice. Seize patients de ces quatre familles ont été étudiés. Tel que prévu, tous les hommes atteints étaient plus sévèrement atteints que les femmes et tous les patients atteints présentaient des caractéristiques électrophysiologiques de démyélinisation.

Conclusion:

Notre étude suggère que la mutation Ser26Trp peut causer une neuropathie démyélinisante primaire qui n'est pas associée à un phénotype clinique spécifique. Nous avons également des données qui démontrent que la majorité des familles ont un ancêtre commun.

Type
Original Article
Copyright
Copyright © The Canadian Journal of Neurological 2001

References

REFERENCES

1. Bergoffen, J, Scherer, SS, Wang, S, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993; 262: 20392042.CrossRefGoogle ScholarPubMed
2. Nelis, E, Haites, N, Van Broeckhoven, C. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum Mutat 1999;13:1128.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
3. Chance, PF, Bird, TD, O’Connell, P, et al. Genetic linkage and heterogeneity in type I Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy type I). Am J Hum Genet 1990; 47:915925.Google ScholarPubMed
4. Fairweather, N, Bell, C, Cochrane, S, et al. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease. Hum Mol Genet 1994; 3:2934.CrossRefGoogle ScholarPubMed
5. Bone, LJ, Dahl, N, Lensch, MW, et al. New connexin 32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology 1995; 45:18631866.CrossRefGoogle ScholarPubMed
6. Ionasescu, V, Ionasescu, R, Searby, C. Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant C harcot-Marie-Tooth neuropathy. Am J Med Genet 1996; 14:486491.3.0.CO;2-I>CrossRefGoogle Scholar
7. Ressot, C, Latour, P, Blanquet Grossard, F, et al. X-linked dominant Charcot-Marie-Tooth neuropathy (CMTX): new mutations in the connexin32 gene. Hum Genet 1996; 98: 172175.CrossRefGoogle ScholarPubMed
8. Tan, CC, Ainsworth, PJ, Hahn, AF, MacLeod, PM. Novel mutations in the connexin gene associated with X-linked Charcot-Marie-Tooth disease. Hum Mutat 1996; 7: 167171.3.0.CO;2-0>CrossRefGoogle ScholarPubMed
9. Janssen, EA, Kemp, S, Hensels, GW, et al. Connexin 32 gene mutations in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Genet 1997; 99:501505 CrossRefGoogle ScholarPubMed
10. Rouger, H, Le Guern, E, Birouk, N, et al. Charcot-Marie-Tooth disease with intermediate motor conduction velocities: Characterization of 14 CX32 mutations in 35 families. Hum Mutat 1997; 10: 443452.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
11. Silander, K, Meretoja, P, Pihko, H, et al. Screening for connexin 32 mutations in Charcot-Marie-Tooth disease families with possible X-linked inheritance. Hum Genet 1997; 100: 391407.CrossRefGoogle ScholarPubMed
12. Philips, LH, Kelly, TE, Schnatterly, P, Parker, D. Hereditary motorsensory neuropathy (HMSN): possible X-linked dominant hereditance. Neurology 1985; 35: 498502.CrossRefGoogle Scholar
13. Nicholson, G, Nash, J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 1993; 43: 25582564.CrossRefGoogle ScholarPubMed
14. Ionasescu, V, Searby, C, Ionasescu, R, Meschino, W. New point mutations and deletions of the connexin 32 gene in X-linked Charcot-Marie-Tooth neuropathy. Neuromuscul Disord 1995; 5: 297299.CrossRefGoogle ScholarPubMed
15. Birouk, N, LeGuern, E, Maisonobe, T, et al. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study. Neurology 1998; 50: 10741082.CrossRefGoogle ScholarPubMed
16. Hahn, A, Bolton, CF, White, CM, et al. Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth. In: Shy, ME, Kamholz, J and Lovelace, RE, eds. Charcot-Marie-Tooth Disorders, NYAcad Sci, 1999; 883:366382.Google ScholarPubMed
17. Birouk, N, Gouider, R, Le Guern, E, et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 1997; 120: 813823.CrossRefGoogle ScholarPubMed
18. Dupré, N, Bouchard, JP, Cossette, L, et al. Clinical and electrophysiological study in French-Canadian population with Charcot-Marie-Tooth disease type 1A associated with 17p11.2 duplication. Can J Neurol Sci, 1999;26:196200.CrossRefGoogle ScholarPubMed
19. Le Guern, E, Ravise, N, Gugenheim, M, et al. Linkage analyses between dominant X-Linked Charcot-Marie- Tooth disease, and 15 Xq11-Xq21 microsatellites in a new large family: three new markers are closely linked to the gene. Neuromuscul Disord 1994; 4: 463469.CrossRefGoogle Scholar
20. MacMillan, JC, Harper, PS. Single-gene neurological disorders in South Wales: an epidemiological study. Ann Neurol 1991;30:411414.CrossRefGoogle ScholarPubMed
21. Combarros, O, Calleja, J, Polo, JM, Berciano, J. Prevalence of hereditary motor and sensory neuropathy in Cantabria. Acta Neurol Scand 1987;75:912.CrossRefGoogle ScholarPubMed
22. Holmberg, BH. Charcot-Marie-Tooth disease in northern Sweden: an epidemiological and clinical study. Acta Neurol Scand 1993;87:416422.CrossRefGoogle ScholarPubMed
23. Baraitser, M. The genetics of neurological disorders. 2nd ed. Motulsky, AG, Bobrow, MB, Harper, PS, Scriver, C, eds. Oxford Monographs on Medical Genetics, vol 18. Oxford, UK: Oxford University Press, 1990:238239.Google Scholar
24. Silander, K, Meretoja, P, Juvonen, V, et al. Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies. Hum Mutat 1998;12:5968.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
25. Hahn, AF, Brown, WF, Koopman, WJ, Feasby, TE. X-linked dominant hereditary motor and sensory neuropathy. Brain 1990;113:15111525.CrossRefGoogle ScholarPubMed
26. Gutierrez, A, England, JD, Summer, AJ, et al. Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease. Muscle Nerve 2000;23:182188.Google Scholar
27. Tabaraud, F, Lagrange, E, Sindou, P, et al. Demyelinating X-linked Charcot-Marie-tooth disease: unusual electrophysiological findings. Muscle Nerve 1999;22:14421447.3.0.CO;2-6>CrossRefGoogle ScholarPubMed
28. Abrams, CK, Oh, S, Ri, Y, Bargiello, TA. Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease. Brain Res Rev 2000;32:203214.CrossRefGoogle ScholarPubMed
29. Oh, S, Ri, Y, Bennett, MV, et al. Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease. Neuron 1997;19:927938.CrossRefGoogle ScholarPubMed